Three key individuals in Surgical Science Sweden AB (publ) (“Surgical Science”); CEO Gisli Hennermark, CFO Anna Ahlberg and CTO Anders Larsson, have agreed on the purchase of a total of 110,000 call options in Surgical Science. The options are issued by the two principal shareholders and board members Jan Bengtsson (Marknadspotential AB) and Roland Bengtsson (Semelin Kapitalförvaltning AB), which means that the call options do not entail any dilution for other shareholders upon exercise.

Holders have the right to acquire one (1) share in Surgical Science for each call option. The term of the options is approximately 2 years and 3 months and exercising the call options can take place between 10 December 2023 and 10 January 2024. The exercise price per share shall amount to SEK 334.60. The price of the call option has been set at SEK 23.10 and has been calculated using Black & Scholes' valuation model.

As of today, the issuers of the options own a total of 14,750,692 shares in Surgical Science, corresponding to 29.0 percent of the shares and votes.

Gothenburg, Sweden, September 23, 2021
Surgical Science Sweden AB (publ)

The press release is available in the attachment or via

https://surgicalscience.com/aktien/pressmeddelanden/

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

For further information, please contact:

Gisli Hennermark, CEO
Telephone: +46-70-420 83 00
E-mail: gisli.hennermark@surgicalscience.com

Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com

About Surgical Science Sweden AB (publ)

One of the biggest challenges within healthcare globally is how injuries during care can be reduced. Medical education and training are key, as a large part of the training today can be performed outside the operating room. Surgical Science is a world leader in the manufacture of virtual reality simulators for evidence-based laparoscopic and endoscopic training. The simulators enable surgeons and other medical specialists to train and improve their psychomotor skills and instrument handling before entering the operating room. In parallel with its own products, Surgical Science works with simulation solutions for medical technology companies that develop surgical instruments for clinical use, such as robotic surgery.

Surgical Science is headquartered in Gothenburg, Sweden and present in Stockholm, Sweden, Tel Aviv, Israel as well as in Seattle, Washington, in the US. Through sales offices in the US, France, China and UAE as well as a global network of distributors, Surgical Science maintains a presence in most markets around the world. Surgical Science Sweden AB (publ) is traded on Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank (Telephone: 08-463 83 00; E-mail: certifiedadviser@penser.se).

Attachments

Principal shareholders issue call options to three key individuals in the company

© Modular Finance, source Nordic Press Releases